Making these compounds is hard, especially since this compound doesnt exist in nature
Their filing for FDA approval of CagriSema in early 2026 puts them on track for a potential approval decision by late 2026 or early 2027
While results can vary and more human studies are needed to validate many of the claims surrounding BPC-157, the early feedback and preclinical research suggest promising directionsespecially when it comes to natural recovery, resilience, and performance support
Key points (quick takeaways) IV detox rehydrates, corrects electrolytes, and delivers critical vitamins it does not flush drugs out. NIAAA IV therapy is commonly used in alcohol withdrawal to prevent complications (e.g., thiamine to reduce risk of serious neurological injury)
BHB supports mitochondrial metabolism In light of the ability of BHB to alter the functionality of CD4 + T cells, we used extracellular flux analysis